💼 About the Role
Hi! As Founder Associate at Yendou, you will be our first non-engineering hire and the right-hand person to Zina, our founder and CEO. Like a swiss-knife, You will own and support many key business functions, including finance, HR, business operations, and investor relations. You will also take on special projects and help coordinate the CEO’s daily activities. This role offers an opportunity to grow into a senior management position as the company scales.
🏢 About Yendou
Yendou is the first CRM designed to help R&D Teams at life sciences companies to scale and accelerate the allocation of cancer clinical trials in clinics, globally.
You might have heard this before: It takes 12 years and $800 million to bring a cancer therapeutic to the market.
But you know what the outsiders don't know?
More than 1/3 of this 12-year timeline (4.6 years) and 22% of the clinical trials costs are spent on the process of clinical trial allocation to clinics.
To solve this problem…
We are creating the first CRM for Pharma, like Salesforce, but with a list of ready-to-go qualified prospects. No more hunting for doctors or hospitals, now they are all on Yendou and companies can shorten the selection timeline by 12 months.
📐 Key Responsibilities:
Business Operations:
Financial Management:
Human Resources:
Investor Relations:
Executive Support:
Special Projects:
Qualifications
Skills:
📈 A competitive salary and Equity Package (0.5% - 1%)
🔨 Interesting and challenging work
💻 Hardware of your choice with a budget of up to 3k
🌴 25 days of paid vacation
🚲 A mobility subscription that reduces or offsets your emissions from commuting.
🎧 A Spotify subscription so you can do your most productive work.
🏋 A fitness subscription so you can clear your head in your time out of the office.
🛣️ What does the hiring process look like?
We will usually respond to applicants before the end of the week, and within 72 hours of each interview.
Applicants can expect the following:
🏢 About Yendou
Yendou is the first CRM designed to help R&D Teams at life sciences companies to scale and accelerate the allocation of cancer [clinical trials](https://en.wikipe…